Published in Am J Med on November 29, 1985
Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med (1995) 8.89
Comparison of micro-ID, API 20E, and conventional media systems in identification of Enterobacteriaceae. J Clin Microbiol (1978) 7.65
Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis (1997) 6.64
Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother (1983) 3.83
Application of computer-assisted interviews to sexual behavior research. Am J Epidemiol (1999) 3.82
Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol (2003) 3.50
Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis. J Clin Microbiol (2000) 3.44
Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus types 1 and 2 from genital ulcers. J Clin Microbiol (1996) 3.19
Serratia marcescens infections from inhalation therapy medications: nosocomial outbreak. Ann Intern Med (1970) 2.94
Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis (1992) 2.93
Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. JAMA (1995) 2.71
Comparison of rapid identification assays for Staphylococcus aureus. J Clin Microbiol (1984) 2.62
Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infections. JAMA (1982) 2.55
A randomized placebo-controlled trial of erythromycin for the treatment of Ureaplasma urealyticum to prevent premature delivery. The Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol (1991) 2.33
Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics. J Infect Dis (1990) 2.19
Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study. Ann Intern Med (1983) 2.17
Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynecol (1996) 2.16
Venezuelan equine encephalitis. Adv Vet Sci Comp Med (1974) 2.12
Interlaboratory variation of antibiograms of methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains with conventional and commercial testing systems. J Clin Microbiol (1983) 2.11
Cellular immune response during uncomplicated genital infection with Chlamydia trachomatis in humans. Infect Immun (1981) 2.03
Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J Clin Microbiol (2000) 2.02
Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations. Antimicrob Agents Chemother (1985) 2.02
Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob Agents Chemother (1990) 1.96
Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial. Clin Infect Dis (2011) 1.92
Confirming positive results of nucleic acid amplification tests (NAATs) for Chlamydia trachomatis: all NAATs are not created equal. J Clin Microbiol (2005) 1.88
Clinical characteristics of bacterial vaginosis among women testing positive for fastidious bacteria. Sex Transm Infect (2008) 1.83
Purulent pericarditis with associated cardiac tamponade caused by a Streptococcus pneumoniae strain highly resistant to penicillin, cefotaxime, and ceftriaxone. Clin Infect Dis (1998) 1.80
The clinical diagnosis of genital ulcer disease in men. Clin Infect Dis (1997) 1.79
Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results. J Clin Microbiol (2001) 1.73
Comparison of the Staph-Ident system with a conventional method for species identification of urine and blood isolates of coagulase-negative staphylococci. J Clin Microbiol (1983) 1.66
Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea. Azithromycin Gonorrhea Study Group. Sex Transm Dis (1997) 1.61
Multicenter in vitro evaluation of SM-7338, a new carbapenem. Antimicrob Agents Chemother (1989) 1.50
Correlation studies of entero-set 20, API 20E and conventional media systems for Enterobacteriaceae identification. J Clin Microbiol (1981) 1.48
Increases in gonorrhea among high school students following hurricane Katrina. Sex Transm Infect (2008) 1.44
Ability of new APTIMA CT and APTIMA GC assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in male urine and urethral swabs. J Clin Microbiol (2005) 1.43
Selective planned induction in conditions of civil strife. Lancet (1975) 1.43
Failure of multiple passages to increase chlamydial recovery. J Clin Microbiol (1987) 1.41
Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species. Antimicrob Agents Chemother (1984) 1.40
Shigellosis in day-care centres. Lancet (1975) 1.38
Demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women. The Vaginal Infections and Prematurity Study Group. Obstet Gynecol (1991) 1.36
Susceptibility of anaerobic bacteria to beta-lactam antibiotics and beta-lactamase production. J Med Microbiol (1983) 1.29
Equating the MOS SF36 and the LSU HSI Physical Functioning Scales. J Outcome Meas (1997) 1.27
Chlamydia trachomatis infections in men with Reiter's syndrome. Ann Intern Med (1984) 1.27
Puerperal infectious morbidity: relationship to route of delivery and to antepartum Chlamydia trachomatis infection. Am J Obstet Gynecol (1980) 1.26
Comparison of the in vitro activity of ciprofloxacin and 24 other antimicrobial agents against clinical strains of Chromobacterium violaceum. Diagn Microbiol Infect Dis (1988) 1.26
Mycoplasma-dependent activation of normal lymphocytes: mitogenic potential of mycoplasmas for mouse lymphocytes. Infect Immun (1977) 1.24
Cefamandole therapy in anaerobic infections. Antimicrob Agents Chemother (1979) 1.22
Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers. Diagn Microbiol Infect Dis (1991) 1.21
Single-dose cefaclor therapy of urinary tract infection. Evaluation of antibody-coated bacteria test and C-reactive protein assay as predictors of cure. Am J Med (1981) 1.20
Alterations in sample preparation increase sensitivity of PCR assay for diagnosis of chancroid. J Clin Microbiol (1995) 1.20
Development of a polymerase chain reaction assay for the detection of Haemophilus ducreyi. Sex Transm Dis (1994) 1.17
Repeated school-based screening for sexually transmitted diseases: a feasible strategy for reaching adolescents. Pediatrics (1999) 1.16
In-vitro study of the susceptibility of cefoxitin/cefotetan resistant Bacteroides fragilis group strains to various other antimicrobial agents. J Antimicrob Chemother (1990) 1.15
Unusual manifestations of invasive pneumococcal infection. Am J Med (1999) 1.14
Study of teaching residents how to teach. J Med Educ (1988) 1.13
Skin and soft tissue infections in critical care. Crit Care Clin (1998) 1.13
Asymptomatic Chlamydia trachomatis infections among sexually active men. J Infect Dis (1986) 1.13
Antibiotic- and method-dependent variation in susceptibility testing results of Bacteroides fragilis group isolates. J Clin Microbiol (1987) 1.13
Epidemiological significance of Venezuelan equine encephalomyelitis virus in vitro markers. Am J Trop Med Hyg (1982) 1.12
Chronic postrheumatic-fever (Jaccoud's) arthritis. Case report with the rheumatoid factor and a family history of rheumatoid arthritis. Arch Intern Med (1967) 1.12
A school-based Chlamydia control program using DNA amplification technology. Pediatrics (1998) 1.11
Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology. Antimicrob Agents Chemother (1990) 1.10
Mycoplasma-dependent activation of normal lymphocytes: induction of a lymphocyte-mediated cytotoxicity for allogeneic and syngeneic mouse target cells. Infect Immun (1977) 1.09
Evaluation of a teaching skills improvement programme for residents. Med Educ (1988) 1.09
Candidal suppurative peripheral thrombophlebitis. Ann Intern Med (1982) 1.08
Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing. Diagn Microbiol Infect Dis (1988) 1.07
In-vitro and in-vivo activity of parenterally administered beta-lactam antibiotics against Chlamydia trachomatis. Sex Transm Dis (1986) 1.07
Ocular infection caused by three unusual marine organisms. Clin Infect Dis (1997) 1.06
Rapid development of bronchiolo-alveolar squamous cell tumors in rats after intratracheal injection of 3-methylcholanthrene. J Natl Cancer Inst (1972) 1.04
In vitro sensitivity of Mycobacterium marinum to minocycline and doxycycline. Tubercle (1978) 1.02
Growth and cytopathology of Mycoplasma synoviae in chicken embryo cell cultures. Infect Immun (1975) 1.02
Isoaccepting transfer RNA's of L-M cells in culture and after tumor induction in C3H mice. Proc Natl Acad Sci U S A (1969) 1.02
Role of imipenem/cilastatin in the treatment of soft tissue infections. Am J Med (1985) 1.01
Elevated mannose levels detected by gas-liquid chromatography in hydrolysates of serum from rats and humans with candidiasis. J Clin Microbiol (1982) 1.01
Clinical and microbiological correlates of vaginal trichomoniasis during pregnancy. The Vaginal Infections and Prematurity Study Group. Clin Infect Dis (1996) 1.00
In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels. Diagn Microbiol Infect Dis (1995) 1.00
Cefamandole and cefoxitin. Ann Intern Med (1985) 1.00
Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria. J Antimicrob Chemother (1986) 0.98
Short-course parenteral antibiotic therapy for pyelonephritis in pregnancy. South Med J (1984) 0.97
A randomized controlled trial of selective planned delivery. Br J Obstet Gynaecol (1978) 0.97
Field studies of an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83). Infect Immun (1972) 0.97
Methicillin hemorrhagic cystitis. Antimicrob Agents Chemother (1977) 0.97
Molecular characterization of Haemophilus ducreyi strains from Jackson, Mississippi, and New Orleans, Louisiana. J Infect Dis (1999) 0.97
N-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteria. Antimicrob Agents Chemother (1982) 0.96
Mycoplasma-dependent activation of normal mouse lymphocytes: requirement for functional T lymphocytes in the cytotoxicity reaction mediated by Mycoplasma arthritidis. Infect Immun (1980) 0.96